From the Fifth International Conference on the

Immunocompromised patients are at high risk for opportunistic infections. Traditionally, these infections were thought to arise from endogenous reactivation of previously acquired latent infections, and nosocomial transmission therefore was deemed to be so unlikely that no special infection control interventions were needed to prevent transmission in healthcare settings. However, new data have challenged this view and suggest that some opportunistic pathogens are transmissible from one immunosuppressed patient to another. Epidemiological investigations, molecular genotyping, animal studies, and air-sampling experiments lend support to the hypothesis that reinfection with opportunistic pathogens does occur, that airborne transmission is possible, and that nosocomial spread is a plausible explanation for case clusters. Taken together, these observations support the view that some opportunistic infections are exogenous in origin and that additional epidemiological investigations are needed to define the true risk of nosocomial spread and need for isolation (Infect Control Hosp Epidemiol 1998;19:574-577) .

[1]  M. Feinberg,et al.  Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Vol. 47/No. RR-5. , 1998 .

[2]  M. Zolfo,et al.  Typing with ITS regions of P. carinii from AIDS patients with recurrent pneumonia , 1997, The Journal of eukaryotic microbiology.

[3]  J. Stringer,et al.  Sequences of Pneumocystis carinii f. sp. hominis strains associated with recurrent pneumonia vary at multiple loci , 1997, Journal of clinical microbiology.

[4]  J. Lundgren,et al.  Transmission of Pneumocystis carinii from patients to hospital staff. , 1997, Thorax.

[5]  R. Miller,et al.  Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia. , 1996, The Journal of infectious diseases.

[6]  H. Oz,et al.  Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. , 1995, The Journal of infectious diseases.

[7]  A. Hoitsma,et al.  Pneumocystis carinii pneumonia in renal transplant recipients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  F. Gigliotti,et al.  Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice , 1995, Infection and immunity.

[9]  Y. Cheung,et al.  An outbreak of Pneumocystis carinii pneumonia in children with malignancy , 1994, Journal of paediatrics and child health.

[10]  K. Sepkowitz,et al.  DNA amplification in experimental pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier states. , 1993, The Journal of infectious diseases.

[11]  M. Millett,et al.  Serum titres of Pneumocystis carinii antibody in health care workers caring for patients with AIDS. , 1993, Thorax.

[12]  J. Sobel,et al.  Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. , 1993, The American journal of medicine.

[13]  T. Quinn,et al.  Geographic variation in the humoral response to Pneumocystis carinii. , 1993, The Journal of infectious diseases.

[14]  F. Meunier,et al.  Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence , 1993, Cancer.

[15]  J. Dauber,et al.  Subclinical pneumonitis due to Pneumocystis carinii in a young adult with elevated antibody titers to Epstein-Barr virus. , 1992, The Journal of infectious diseases.

[16]  W D Hueston,et al.  Bovine spongiform encephalopathy: case-control studies of calf feeding practices and meat and bonemeal inclusion in proprietary concentrates. , 1992, Research in veterinary science.

[17]  P. Francioli,et al.  Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. , 1991, AIDS.

[18]  A. Heryet,et al.  Observations favouring Pneumocystis carinii pneumonia as a primary infection: a monoclonal antibody study on paraffin sections , 1988, The Journal of pathology.

[19]  J. Kovacs,et al.  Identification of antigens and antibodies specific for Pneumocystis carinii. , 1988, Journal of immunology.

[20]  A. Craft,et al.  Serological study of Pneumocystis carinii infection in the absence of immunosuppression. , 1987, Archives of disease in childhood.

[21]  B. Jameson,et al.  Pneumocystis carinii pneumonitis: a serological study. , 1979, Journal of clinical pathology.

[22]  W. Hughes,et al.  Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. , 1978, Pediatrics.

[23]  D. Armstrong,et al.  Pneumocystis carinii pneumonia: a cluster of eleven cases. , 1975, Annals of internal medicine.

[24]  J. Lewis Pneumocystis carinii pneumonia in a hospital for children , 1971 .

[25]  A. Björkman,et al.  No evidence of nosocomial Pneumocystis carinii infection via health care personnel. , 1997, Scandinavian journal of infectious diseases.

[26]  C. Beard,et al.  Molecular epidemiology of Pneumocystis carinii pneumonia. , 1996, Emerging infectious diseases.

[27]  J. Cabane,et al.  Le risque de pneumocystose nosocomiale chez les immunodéprimés non infectés par le virus de l'immunodéficience humaine (VIH) , 1994 .

[28]  K. Elvin Laboratory diagnosis and occurrence of Pneumocystis carinii. , 1994, Scandinavian journal of infectious diseases. Supplementum.

[29]  J. Nielsen,et al.  IgM response to a human Pneumocystis carinii surface antigen in HIV-infected patients with pulmonary symptoms. , 1993, Scandinavian journal of infectious diseases.